BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23561652)

  • 1. Effects of treatment duration during concomitant chemoradiation therapy for cervical cancer.
    Shaverdian N; Gondi V; Sklenar KL; Dunn EF; Petereit DG; Straub MR; Bradley KA
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):562-8. PubMed ID: 23561652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
    Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F
    BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.
    Marnitz S; Martus P; Köhler C; Stromberger C; Asse E; Mallmann P; Schmidberger H; Affonso Júnior RJ; Nunes JS; Sehouli J; Budach V
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):243-53. PubMed ID: 26853333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of concomitant cisplatin plus radiotherapy versus radiotherapy alone in patients with stage IIIB squamous cervical cancer: A randomized controlled trial.
    Fachini AMD; Zuliani AC; Sarian LO; Teixeira JC; Esteves SCB; da Costa Machado H; Zeferino LC
    Gynecol Oncol; 2021 Feb; 160(2):379-383. PubMed ID: 33341239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in definitive radiotherapy of uterine cervical cancer.
    Yalman D; Aras AB; Ozkök S; Duransoy A; Celik OK; Ozsaran Z; Haydaroğlu A
    Eur J Gynaecol Oncol; 2003; 24(3-4):309-14. PubMed ID: 12807246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC; Wang L; Lin JC; Jan JS
    J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Survival Rates and Prognostic Factors of Cervix Cancer Treated by Different Modalities.
    Viani GA; Dos Santos FM; Pavoni JF
    Am J Clin Oncol; 2020 Jan; 43(1):52-57. PubMed ID: 31764019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.
    Ho JC; Allen PK; Bhosale PR; Rauch GM; Fuller CD; Mohamed AS; Frumovitz M; Jhingran A; Klopp AH
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):546-553. PubMed ID: 28011045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Brachytherapy Boost and Dose-escalated External Beam Radiotherapy in Margin Positive Cervical Cancer Treated With Chemotherapy and Radiation.
    Ager BJ; Torgeson A; Francis SR; Burt LM; Gaffney DK; Cannon DM
    Am J Clin Oncol; 2020 Jan; 43(1):35-42. PubMed ID: 31764024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Data-Derived Treatment Duration Goal for Cervical Cancer: Should 8 Weeks Remain the Target in the Era of Concurrent Chemoradiation?
    Hong JC; Foote J; Broadwater G; Sosa JA; Gaillard S; Havrilesky LJ; Chino JP
    JCO Clin Cancer Inform; 2017 Nov; 1():1-15. PubMed ID: 30657372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of chemoradiotherapy in cervical cancer--the Western Australian experience.
    Lim A; Sia S
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1431-8. PubMed ID: 21640504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma.
    Schefter T; Winter K; Kwon JS; Stuhr K; Balaraj K; Yaremko BP; Small W; Sause W; Gaffney D;
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):101-5. PubMed ID: 24331655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of treatment results and prognostic factors in early-stage cervical carcinoma patients treated with postoperative radiotherapy or radiochemotherapy.
    Demirci S; Ozsaran Z; Ozsaran A; Yavas F; Demircioglu B; Hanhan M; Dikmen Y; Aras AB
    Eur J Gynaecol Oncol; 2012; 33(1):62-7. PubMed ID: 22439408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy.
    Hu K; Wang W; Liu X; Meng Q; Zhang F
    Radiat Oncol; 2018 Dec; 13(1):249. PubMed ID: 30558636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant cisplatin plus radiotherapy and high-dose-rate brachytherapy versus radiotherapy alone for stage IIIB epidermoid cervical cancer: a randomized controlled trial.
    Zuliani AC; Esteves SC; Teixeira LC; Teixeira JC; de Souza GA; Sarian LO
    J Clin Oncol; 2014 Feb; 32(6):542-7. PubMed ID: 24449243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128.
    Viswanathan AN; Moughan J; Small W; Levenback C; Iyer R; Hymes S; Dicker AP; Miller B; Erickson B; Gaffney DK
    Int J Gynecol Cancer; 2012 Jan; 22(1):123-31. PubMed ID: 22193645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
    Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
    Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locally Advanced Cervical Cancer: Outcomes With Variable Adherence to Treatment.
    Manders DB; Morón A; McIntire D; Miller DS; Richardson DL; Kehoe SM; Albuquerque KV; Lea JS
    Am J Clin Oncol; 2018 May; 41(5):447-451. PubMed ID: 27258678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results and prognostic factors in patients with stage III-IVA squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy from a single institution study.
    Kudaka W; Nagai Y; Toita T; Inamine M; Asato K; Nakamoto T; Wakayama A; Ooyama T; Tokura A; Murayama S; Aoki Y
    Int J Clin Oncol; 2013 Oct; 18(5):916-21. PubMed ID: 22898910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: A review of the National Cancer Database.
    Rao YJ; Chin RI; Hui C; Mutch DG; Powell MA; Schwarz JK; Grigsby PW; Markovina S
    Gynecol Oncol; 2017 Sep; 146(3):572-579. PubMed ID: 28662775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.